The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?

Sodium–glucose cotransporter-2 (SGLT-2) inhibitors, also called gliflozins or flozins, are a class of drugs that have been increasingly used in the management of type 2 diabetes mellitus (T2DM) due to their glucose-lowering, cardiovascular (CV), and renal positive effects. However, recent studies su...

Descripción completa

Detalles Bibliográficos
Autores principales: Koutentakis, Michail, Kuciński, Jakub, Świeczkowski, Damian, Surma, Stanisław, Filipiak, Krzysztof J., Gąsecka, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672595/
https://www.ncbi.nlm.nih.gov/pubmed/37998523
http://dx.doi.org/10.3390/jcdd10110465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672595/
https://www.ncbi.nlm.nih.gov/pubmed/37998523
http://dx.doi.org/10.3390/jcdd10110465

Ejemplares similares